Legislation to broaden federal regulation of compounding pharmacies like the one linked to last year’s meningitis deaths may reach President Barack Obama’s desk in days after clearing a procedural hurdle in the U.S. Senate.
Legislation that would broaden federal regulation of compounding pharmacies like the one linked to last year’s meningitis deaths cleared a procedural hurdle in the U.S. Senate and could be on the desk of President Barack Obama within days.
U.S. farmers may lose as much as 4 million acres (1.6 million hectares) of annual soybean production if regulators move too quickly to ban trans fats in processed food, according to the American Soybean Association.
After two decades of battles by public health advocates, the artery clogging trans fats common in cookies, frozen pizzas and other processed foods have been deemed unsafe by U.S. regulators, opening the door to a ban.
The top U.S. drug regulator asked Congress for more authority over pharmacies following the deadly meningitis outbreak, a request met with resistance by lawmakers who said existing oversight hasn’t been used to the fullest.
Hospital pharmacists are backing a call by the Food and Drug Administration for added regulation of compounding companies after a meningitis outbreak, calling it a “gray area” with serious implications.
Obesity treatments, life-saving antibiotics and other drugs deemed to offer societal benefit despite their risks may get speedier U.S. approvals under plans being discussed to better balance innovation and safety.